Misoprostol in the management of retained placenta, a safe alternative for manual removal? A randomised controlled trial
Phase 3
Completed
- Conditions
- retained placenta10010273
- Registration Number
- NL-OMON30364
- Lead Sponsor
- Academisch Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
All women with at least 25 completed pregnancy weeks and retained placenta (the placenta has not been born within 60 minutes after the birth of the child), in the abcense of postpartum haemorrhage.
Exclusion Criteria
Excessive blood loss (>1000 ml) within 60 minutes after the delivery of the newborn. Allergy for misoprostol or one of its components.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Number of manual removals and amount of blood loss.</p><br>
- Secondary Outcome Measures
Name Time Method <p>Interval between administration of misoprostol and delivery of the placenta,<br /><br>placenta captiva.<br /><br>Possible side effects of misoprostol; diarrhoea, abdominal pain, nausea,<br /><br>dyspepsia, vomiting, headache and dizziness.</p><br>